Results 11 to 20 of about 27,492 (267)

INHALATION. [PDF]

open access: yesThe Lancet, 1902
n ...
openaire   +1 more source

Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease [PDF]

open access: yesTuberculosis and Respiratory Diseases, 2021
Background The aim of this study was to investigate inhaler device handling in elderly patients. Inhaler devices with respect to misuse and error correction were also compared.
Ha Youn Lee   +7 more
doaj   +1 more source

Origanum vulgar inhaler in the treatment of chronic rhinosinositis, a double blind placebo controlled randomized clinical trial [PDF]

open access: yesJournal of Mazandaran University of Medical Sciences, 2007
Background and purpose: Symptoms of chronic rhinisinositis (CRS) are cumbersome and refractory to most systemic medications and even after surgical intervention, the recurrence of symptoms are frequent.
K. Rabie   +4 more
doaj  

Inhalation therapy in children

open access: yesPediatria i Medycyna Rodzinna, 2014
Inhalation is a form of treatment used in respiratory diseases that allows medications to be administered directly to the affected site. Thanks to this, the administration of lower doses helps obtain a higher concentration in the target organ and ...
Jolanta Pietrzak   +2 more
doaj   +1 more source

The environmental impact of inhaler replacement: A carbon footprint and economic calculation of the National Database of Health Insurance Claims in Japan

open access: yesJournal of General and Family Medicine, 2023
Background Drugs are a major source of greenhouse gas (GHG) emissions from healthcare systems. Pressurized metered‐dose inhalers (pMDIs) have raised concerns over their environmental impact due to GHG emissions.
Kazuya Nagasaki   +3 more
doaj   +1 more source

Advances in Pulmonary Drug Delivery

open access: yesPharmaceutics, 2020
Pulmonary drug delivery represents an attractive, non-invasive administration option. In addition to locally acting drugs, molecules that are intended to produce systemic effects can be delivered via the pulmonary route.
Ayca Yıldız-Peköz, Carsten Ehrhardt
doaj   +1 more source

Current approaches to management of patients with pulmonary hypertension

open access: yesМедицинский совет, 2014
Pulmonary hypertension is a group of diseases characterized by progressive increase in pulmonary vascular resistance leading to right ventricular failure and premature mortality.
S. N. Avdeev
doaj   +1 more source

Interchanging Reusable and Disposable Nebulizers Used with Home-Based Compressors May Result in Inconsistent Dosing: A Laboratory Investigation with Device Combinations Supplied to the US Healthcare Environment

open access: yesPulmonary Therapy
Introduction Reusable nebulizer–compressor combinations deliver inhaled medications for patients with chronic lung diseases. On hospital discharge, the patient may take home the disposable nebulizer that was packaged and combine it with their home ...
Judy Schloss   +4 more
doaj   +1 more source

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

open access: yesFEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes   +3 more
wiley   +1 more source

Oscillating Positive Expiratory Pressure (OPEP) Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review of Clinical Studies

open access: yesPulmonary Therapy
Exacerbations associated with bronchiectasis with or without chronic obstructive pulmonary disease (COPD) are often associated with generation and accumulation of excessive mucus in the airways of the lungs.
Judy L. Schloss   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy